Citations

Clear

6 citation(s) found for "Claxton, Matthew R".

Prevalence and clinical characteristics of age-related distance esotropia
Claxton, Matthew R., Bang, Genie M., Martinez‐Thompson, Jennifer M. , Hodge, David O. , Mohney, Brian G., Martinez-Thompson, Jennifer, Claxton, Matthew R.

Mayo Clinic

Strabismus | July 8, 2022 | Volume: 30 | Issue: 3 | Pages: 115-120

10.1080/09273972.2022.2097707 | PMID 35799374 Get It

Outcomes of Pyrocarbon Arthroplasty in Metacarpophalangeal Joints Affected by Rheumatoid Arthritis
Cummings, Paige , Mohney, Brian G. , Rizzo, Marco , Cummings, Paige E , Claxton, Matthew R , Rizzo, Marco , Wagner, Eric R.

Mayo Clinic

HAND | January 19, 2022 | Volume: 18 | Issue: 6 | Pages: 931-937

10.1177/15589447211063577 | PMID 35043719 Get It

Background: Rheumatoid arthritis (RA) affecting the metacarpophalangeal (MCP) joint may warrant arthroplasty. The purpose of this study was to investigate implant survivorship, complications, radiographic outcomes, and clinical outcomes in patients undergoing MCP arthroplasty with a pyrocarbon implant to treat RA. Methods: In all, 124 MCP joint pyrocarbon arthroplasties in 40 patients performed to treat RA were reviewed. Operations were at the index (n = 43, 35%), middle (n = 33, 27%), ring (n = 27, 22%), and small (n = 21, 17%) fingers from 1998 to 2009 in 105 (85%) female and 19 (15%) male joints with a mean age of 54 ± 11 years. Mean postoperative follow-up was 6 ± 3 years. All patients achieved at least 2 years of follow-up. Results: Rates of implant survivorship at 1, 2, 5, and 10 years were 98%, 98%, 90%, and 81%, respectively. Fifteen percent (n = 18) of arthroplasties underwent revision at a mean 5 ± 3 years postoperatively. The overall reoperation rate was 29% (n = 36). Rates of survival from reoperation at 1, 2, 5, and 10 years were 85%, 84%, 76%, and 68%, respectively. Complications occurred in 32% (n = 40). Pain ratings improved postoperatively ( P < .01). Arc of motion improved from 37 ± 21 to 43 ± 19 ( P = .03). Both appositional and oppositional strength improved after surgery; however, there was no improvement in grip strength ( P < .01). Conclusions: Metacarpophalangeal arthroplasty with a pyrocarbon implant demonstrated reliable improvement in pain and arc of motion in patients with RA. Complication and overall reoperation rates were high, while 1 in 10 undergo revision within 5 years postoperatively.
Genetic Alterations in Melanocytoma Associated with Oculodermal Melanocytosis: Molecular Characteristics
Claxton, Matthew R., Guo, Ruifeng , Tooley, Andrea A. , Guo, Ruifeng , Claxton, Matthew R., Dalvin, Lauren A.

Mayo Clinic

Ophthalmic Plastic & Reconstructive Surgery | December 17, 2021 | Volume: 38 | Issue: 3 | Pages: e77-e80

10.1097/iop.0000000000002115 | PMID 34919071 Get It

Melanocytoma is a benign tumor with histologic similarity to oculodermal melanocytosis, which can undergo malignant transformation in rare cases. Melanocytoma more commonly involves the optic disc, and few cases of orbital melanocytoma have been reported. Primary orbital melanoma is a rare malignancy known to arise from pigmentary conditions, although there is little information on this tumor arising from melanocytoma. The authors present a case of malignant transformation of orbital melanocytoma in the setting of ipsilateral oculodermal melanocytosis. This case illustrates histopathologic features associated with malignant transformation and highlights the significance of GNAQ, BAP1, and specific intrachromosomal alterations occurring in oculodermal melanocytosis and melanocytoma. The molecular markers observed in this case are of interest as they have overlap with those present in uveal melanoma. This case demonstrates a timeline of genetic and molecular alterations occurring in the malignant transformation of orbital melanocytoma.
Outcomes of Surface Replacement Arthroplasty in Metacarpophalangeal Joints Affected by Noninflammatory Arthritis
Mohney, Brian G. , Rizzo, Marco , Claxton, Matthew R , Rizzo, Marco , Wagner, Eric R.

Mayo Clinic

HAND | July 31, 2021 | Volume: 18 | Issue: 3 | Pages: 463-468

10.1177/15589447211028917 | PMID 34330177 Get It

Background The purpose of this study was to investigate the outcomes of surface replacement arthroplasty (SRA) for noninflammatory arthritis of the metacarpophalangeal (MCP) joint. Methods Records from 20 SRAs performed between 1995 and 2017 in 17 patients with noninflammatory arthritis affecting the MCP joint were retrospectively reviewed. The mean follow up was 6.6 years. Results Three arthroplasties (15%) underwent 4 revision operations. The 2-, 5-, 10-, and 15-year rates of survival from surface replacement implant revision were 90%, 90%, 79%, and 79%, respectively. Major complications occurring in revised joints included arthrodesis (n = 1) and amputation (n = 1). The overall reoperation rate was 35%. The 2-, 5-, 10-, and 15-year rates of overall reoperation-free survival were 75%, 69%, 60%, and 60%, respectively. Conclusions Pain ratings and MCP arc of motion significantly improved following arthroplasty. Metacarpophalangeal SRA for noninflammatory arthritis can improve arc of motion and pain. Revision is uncommon; however, 1 in 3 joints requires reoperation.
Extraskeletal myxoid chondrosarcoma: A high incidence of metastatic disease to lymph nodes
Claxton, Matthew R., Reynolds, Grace L., Wenger, Doris E. , Rose, Peter S. , Houdek, Matthew T. , Reynolds, Grace, Houdek, Matthew T , Claxton, Matthew R., Reynolds, Grace

Mayo Clinic

Journal of Surgical Oncology | August 28, 2020 | Volume: 122 | Issue: 8 | Pages: 1662-1667

10.1002/jso.26179 | PMID 32808356 Get It

AbstractBackgroundExtraskeletal myxoid chondrosarcoma (ESMC) is a rare type of soft‐tissue sarcoma with limited series reporting outcome of treatment. Currently there is limited data on the incidence and impact on patient outcome in those with metastatic disease to lymph nodes in ESMC.MethodsThirty (21 males, 9 females) patients, mean age 50 ± 16 years, with ESMC were reviewed. The tumors were most commonly located in the lower extremity (n = 23, 77%) and the mean tumor size and volume were 9 ± 5 cm and 490 ± 833 cm3. Mean follow up was 7 ± 4 years.ResultsSix (20%) patients either presented (n = 3, 10%) or developed (n = 3, 10%) lymph node metastatic disease. When comparing patients without, with lymph node metastasis and metastasis elsewhere, patients with lymph nodes metastasis had worse survival than those without metastasis, however better 10‐year disease specific survival than those with metastasis elsewhere (100% vs 62% vs 0%; P < .001).ConclusionThere is a high incidence of lymph node metastatic disease in patients with ESMC. Although survival in these patients is worse compared to those without metastasis, their survival is better than those with metastasis elsewhere. Due to the high incidence of lymph node metastatic disease, preoperative staging of the lymph node should be considered.
Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis
Mohney, Brian G. , Rizzo, Marco , Claxton, Matthew R , Rizzo, Marco , Wagner, Eric R.

Mayo Clinic

HAND | June 3, 2020 | Volume: 17 | Issue: 2 | Pages: 271-277

10.1177/1558944720926631 | PMID 32486855 Get It

Background: Surface replacement arthroplasty (SRA) can be used in the treatment of rheumatoid arthritis (RA) affecting the metacarpophalangeal (MCP) joint. The authors of this study sought to investigate the outcomes of MCP SRA in patients with RA. Methods: Retrospective review of medical records and an institutional joint registry were used to gather data on 80 MCP SRAs performed in 27 patients with RA. Data collected included demographics, SRA revisions, reoperations, complications, pain, and MCP arc of motion. Results: The mean postoperative follow-up was 9.5 years (range, 2.1-20.5 years), with all SRAs achieving at least 2 years of follow-up. Thirteen digits (16%) underwent revision arthroplasty, and 29 (36%) required reoperation. The 5-, 10-, 15-, and 20-year rates of survival from implant revision were 95%, 85%, 80%, and 69%, respectively. The 5-, 10-, 15-, and 20-year rates of survival from overall reoperation were 80%, 65%, 55%, and 46%, respectively. Metacarpophalangeal joint arc of motion, grip strength, and pain levels significantly improved following surgery. Conclusions: Metacarpophalangeal SRA can offer benefit to patients with RA for improvement in function and pain. High overall reoperation rates remain concerning; however, most do not involve arthroplasty revision.